Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-129381
Filing Date
2015-04-14
Accepted
2015-04-14 16:22:10
Documents
7
Period of Report
2015-06-04
Effectiveness Date
2015-04-14

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d895439ddef14a.htm DEF 14A 498354
2 GRAPHIC g895439dsp_044a.jpg GRAPHIC 53158
3 GRAPHIC g895439dsp_044b.jpg GRAPHIC 46245
4 GRAPHIC g895439dsp_044c.jpg GRAPHIC 18148
5 GRAPHIC g895439dsp_044d.jpg GRAPHIC 19763
6 GRAPHIC g895439dsp_044e.jpg GRAPHIC 44816
7 GRAPHIC g895439pc_pg01.jpg GRAPHIC 8102
  Complete submission text file 0001193125-15-129381.txt   762621
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22873 | Film No.: 15769455
SIC: 2835 In Vitro & In Vivo Diagnostic Substances